Overview

Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure with Preserved Ejection Fraction

Status:
COMPLETED
Trial end date:
2023-09-17
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the potential of Pogejiuxin Decoction to enhance the efficacy and mitigate the adverse effects associated with conventional treatment in patients with heart failure and preserved ejection fraction(HFpEF), thereby establishing a foundation for its clinical application in managing HFpEF.
Phase:
NA
Details
Lead Sponsor:
Chongqing Traditional Chinese Medicine Hospital
Collaborators:
Chongqing Health and Family Planning Commission
Chongqing Science and Technology Commission